Search research articles
Contact Us
Filters
Showing results (51-60 of 260) with videos related to
Page
of 26
Sort By:
Biochemical Pharmacology
|
April 1, 1980
Mutagenic potential of allyl and allylic compounds. Structure-activity relationship as determined by alkylating and direct in vitro mutagenic properties
E Eder, T Neudecker, D Lutz, et al.
Biochemical Pharmacology
|
October 1, 1980
Structure-activity relationship in halogen and alkyl substituted allyl and allylic compounds: correlation of alkylating and mutagenic properties
T Neudecker, D Lutz, E Eder, et al.
Wiener Klinische Wochenschrift
|
August 6, 1982
[Diagnosis of leukemia with monoclonal antibodies]
O Majdic, P Bettelheim, K Liszka, et al.
Zeitschrift Fur Rheumatologie
|
July 1, 1989
[Development of a new quantitative rheumatoid factor test]
D Lutz, J Hönes, P Fritz, et al.
European Journal of Haematology
|
January 1, 1992
Remission may continue after termination of rIFN alpha-2b treatment for essential thrombocythemia
H Kasparu, M Bernhart, O Krieger, et al.
Chemico-Biological Interactions
|
February 1, 1982
Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigation
E Eder, T Neudecker, D Lutz, et al.
Blood
|
December 1, 1981
Myeloid differentiation antigen defined by a monoclonal antibody
O Majdic, K Liszka, D Lutz, et al.
Arzneimittel-Forschung
|
November 1, 1987
[Biotransformation and bioequivalence of a new nifedipine preparation]
G Achtert, R Wisotzki, D Lutz, et al.
International Journal of Cosmetic Science
|
April 10, 2016
New approach for a reliable in vitro sun protection factor method - Part II: Practical aspects and implementations
S Miksa, D Lutz, C Guy, et al.
Cancer Genetics and Cytogenetics
|
October 1, 1986
Hypo- and hypertetraploidy in a case of erythroleukemia analyzed by fluorochrome banding techniques
M Lambrou, H Nowotny, D Lutz, et al.
Page
of 26
Search research articles
Search
Showing results (51-60 of 260) with videos related to
Sort By:
Page
of 26
Biochemical Pharmacology
|
April 1, 1980
Mutagenic potential of allyl and allylic compounds. Structure-activity relationship as determined by alkylating and direct in vitro mutagenic properties
E Eder, T Neudecker, D Lutz, et al.
Biochemical Pharmacology
|
October 1, 1980
Structure-activity relationship in halogen and alkyl substituted allyl and allylic compounds: correlation of alkylating and mutagenic properties
T Neudecker, D Lutz, E Eder, et al.
Wiener Klinische Wochenschrift
|
August 6, 1982
[Diagnosis of leukemia with monoclonal antibodies]
O Majdic, P Bettelheim, K Liszka, et al.
Zeitschrift Fur Rheumatologie
|
July 1, 1989
[Development of a new quantitative rheumatoid factor test]
D Lutz, J Hönes, P Fritz, et al.
European Journal of Haematology
|
January 1, 1992
Remission may continue after termination of rIFN alpha-2b treatment for essential thrombocythemia
H Kasparu, M Bernhart, O Krieger, et al.
Chemico-Biological Interactions
|
February 1, 1982
Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigation
E Eder, T Neudecker, D Lutz, et al.
Blood
|
December 1, 1981
Myeloid differentiation antigen defined by a monoclonal antibody
O Majdic, K Liszka, D Lutz, et al.
Arzneimittel-Forschung
|
November 1, 1987
[Biotransformation and bioequivalence of a new nifedipine preparation]
G Achtert, R Wisotzki, D Lutz, et al.
International Journal of Cosmetic Science
|
April 10, 2016
New approach for a reliable in vitro sun protection factor method - Part II: Practical aspects and implementations
S Miksa, D Lutz, C Guy, et al.
Cancer Genetics and Cytogenetics
|
October 1, 1986
Hypo- and hypertetraploidy in a case of erythroleukemia analyzed by fluorochrome banding techniques
M Lambrou, H Nowotny, D Lutz, et al.
Page
of 26